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Abstract
Rationale Interval timing in the free-operant psychophysical
procedure is sensitive to the monoamine-releasing agent d-
amphetamine, the D2-like dopamine receptor agonist
quinpirole, and the D1-like agonist 6-chloro-2,3,4,5-tetra-
hydro-1-phenyl-1H-3-benzepine (SKF-81297). The effect
of d-amphetamine can be antagonized by selective D1-like
and 5-HT2A receptor antagonists. It is not known whether
d-amphetamine’s effect requires an intact 5-hydroxytryptamine
(5-HT) pathway.
Objective The objective of this study was to examine the
effects of d-amphetamine, quinpirole, and SKF-81297 on
timing in intact rats and rats whose 5-hydroxytryptaminergic
(5-HTergic) pathways had been ablated.
Materials and methods Rats were trained under the free-
operant psychophysical procedure to press levers A and B
in 50-s trials in which reinforcement was provided
intermittently for responding on A in the first half, and B
in the second half of the trial. Percent responding on B (%
B) was recorded in successive 5-s epochs of the trials;
logistic functions were fitted to the data for derivation of
timing indices (T50, time corresponding to %B=50%;
Weber fraction). The effects of d-amphetamine (0.4 mg
kg
−1 i.p.), quinpirole (0.08 mg kg
−1 i.p.), and SKF-81297
(0.4 mg kg
−1 s.c.) were compared between intact rats and
rats whose 5-HTergic pathways had been destroyed by
intra-raphe injection of 5,7-dihydroxytryptamine.
Results Quinpirole and SKF-81297 reduced T50 in both
groups; d-amphetamine reduced T50 only in the sham-
lesioned group. The lesion reduced 5-HT levels by 80%;
catecholamine levels were not affected.
Conclusions d-Amphetamine’s effect on performance in the
free-operant psychophysical procedure requires an intact 5-
HTergic system. 5-HT, possibly acting at 5-HT2A receptors,
may play a ‘permissive’ role in dopamine release.
Keywords Timing.Free-operantpsychophysical
procedure.D1-like dopamine receptors.D2-like dopamine
receptors.5-HTergicpathways.5,7-dihydroxytryptamine.
d-Amphetamine.SKF-81297.Quinpirole
Introduction
Interval timing behavior in animals can be divided into two
broad categories—temporal discrimination, where an animal
learns to emit different responses depending on the duration
of an external stimulus (e.g., a light or tone), and temporal
differentiation, where the animal’s behavior comes under the
control of time during an ongoing interval (Killeen and
Fetterman 1988; Killeen et al. 1997). This paper is
concerned with the psychopharmacology of temporal
differentiation.
Temporal differentiation is revealed by immediate timing
schedules, an example of which is the free-operant
psychophysical procedure (Stubbs 1976, 1980), in which
reinforcement is provided intermittently for responding on
two operanda, A and B; responding on A is reinforced in
the first half and responding on B in the second half of each
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quantitatively from the psychophysical function relating
proportional responding on B (%B) to time measured from
the onset of the trial. This function has a logistic form,
characterized by the indifference point, T50 (the time at
which %B=50), and a slope parameter, ɛ; these parameters
may be used to derive the Weber fraction, an index of the
precision of temporal differentiation (see Killeen and
Fetterman 1988; Gibbon et al. 1997; Ho et al. 2002). In
the free-operant psychophysical procedure, the Weber
fraction is generally expressed as the ratio of the limen
([T75−T25]/2, i.e., half the difference between the times
corresponding to %B=75 and %B=25) to T50. Thus, a low
Weber fraction signifies a relatively steep psychometric
function, in other words, precise temporal differentiation.
There is a substantial body of evidence for the
involvement of central dopaminergic mechanisms in the
control of interval timing behavior (see Meck 1996, 2006;
Gibbon et al. 1997; Hinton and Meck 1997; Meck and
Benson 2002; MacDonald and Meck 2004;). In the free-
operant psychophysical procedure, the psychostimulant d-
amphetamine, which is known to release dopamine,
produces a leftward shift in the psychophysical function,
which is reflected as a reduction of T50 (Chiang et al.
2000a; Cheung et al. 2006; Body et al. 2006b). The effects
of d-amphetamine and other dopamine-releasing agents
have generally been attributed to the stimulation of
postsynaptic D2 dopamine receptors (Meck 1986, 1996).
1
Consistent with this hypothesis, it has been found that the
D2 dopamine receptor agonist quinpirole can reduce T50 in
the free-operant psychophysical procedure (Cheung et al.
2007a). However, it has recently been demonstrated that the
selective D1 dopamine receptor agonist 6-chloro-2,3,4,5-
tetrahydro-1-phenyl-1H-3-benzazepine (SKF-81927) has a
qualitatively similar effect on performance in the free-
operant psychophysical procedure to that of d-amphetamine
(Cheung et al. 2007b). Moreover, the reduction of T50
produced by d-amphetamine can be antagonized by a
selective D1 dopamine receptor antagonist 8-bromo-
2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-
ol (SKF-83566), but not by the D2 receptor antagonist
haloperidol (Cheung et al. 2007b), indicating an involvement
of D1 dopamine receptors in d-amphetamine’se f f e c t so n
timing behavior in this schedule.
Manipulation of the 5-hydroxytryptaminergic (5-HTergic)
system has also been shown to influence timing performance
in the free-operant psychophysical procedure. Administra-
tion of the 5-HT2A/2C receptor agonist DOI produces a
leftward shift in the psychophysical curve, which can be
attenuated by the 5-HT2A receptor antagonists ketanserin and
MDL-100907 (Body et al. 2003, 2006a). Interestingly, the
highly selective 5-HT2A receptor antagonist MDL-100907 is
also able to attenuate the effect of d-amphetamine on timing
performance in this schedule, suggesting a functional
interaction between D1 dopamine receptors and 5-HT2A
receptors (Body et al. 2006b).
Displacement of the psychometric function in interval
timing schedules is not the only behavioral effect of
d-amphetamine that has been shown to depend upon
5-HTergic mechanisms. For example, 5-HT2A receptor
antagonists have been shown to antagonize d-amphetamine-
induced hyperlocomotion (Sorenson et al. 1993; Moser et al.
1996;O ’Neill et al. 1999) and d-amphetamine-induced
disruption of latent inhibition (Moser et al. 1996). Forebrain
5-HT depletion has been found to attenuate some of d-
amphetamine’s behavioral effects, including the disruption of
performance in the five-choice serial reaction time task and
the reduction of tolerance of delay of reinforcement
(Harrison et al. 1997; Winstanley et al. 2003). However,
some behavioral effects of d-amphetamine appear to be
impervious to central 5-HT depletion; for example, Fletcher
et al. (1999) found no effect of 5-HT depletion on the
reinforcing effect of d-amphetamine using a variety of self-
administration schedules. It is not known whether central
5-HTdepletionalterstheabilityofd-amphetamine to displace
the psychometric timing function.
The present experiment examined whether d-amphet-
amine’s effect on temporal differentiation performance in
the free-operant psychophysical procedure depends upon an
intact 5-HTergic system. The effect of d-amphetamine on
temporal differentiation was compared between intact
rats and rats whose ascending 5-HTergic pathways had
been ablated by injection of the selective neurotoxin 5,7-
dihydroxytryptamine into the dorsal and median raphe
nuclei. In addition to d-amphetamine, an ‘indirect’ dopamine
receptor agonist, we also examined the effects of a ‘direct’
D1 dopamine receptor agonist, SKF-81297, and a ‘direct’ D2
dopamine receptor agonist, quinpirole.
Materials and methods
The experiment was carried out in accordance with UK
Home Office regulations governing experiments on living
animals and was approved by the local ethical review
committee.
1 Most drugs acting at D1 dopamine receptors do not discriminate
between D1 and D5 dopamine receptors and are therefore more
precisely designated D1-like receptor agonists and antagonists.
Similarly, most drugs acting at D2 receptors do not discriminate
between D2,D 3, and D4 receptors and are therefore designated D2-like
receptor agonists and antagonists (Alexander et al. 2008). Throughout
this paper, for the sake of simplicity, they are referred to as D1 and D2
receptor agonists and antagonists.
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Twenty-four female Wistar rats aged approximately
4 months and weighing 250–300 g at the start of the
experiment were used. They were housed individually
under a constant cycle of 12 h light and 12 h darkness
(lights on at 0700–1900 h) and were maintained at 80% of
their initial free-feeding body weights by providing a limited
amount of standard rodent diet after each experimental
session. Tap water was freely available in the home cage.
Surgery
The rats received either lesions of the dorsal and median
raphe nuclei (n=11) or sham lesions (n=13). Our methods
for the surgical preparation of the rats have been described
in detail elsewhere (Wogar et al. 1992). Rats were
anesthetized with 4% isoflurane in oxygen and placed in a
stereotaxic apparatus; anesthesia was maintained with 2%
isoflurane in oxygen during the surgery. The following
stereotaxic coordinates (Paxinos and Watson 1998) were
used to locate the median and dorsal raphe nuclei: AP +1.2,
L, 0.0, DV +1.5 (dorsal) +3.5 (median), measured from the
interaural line, with the incisor bar fixed 3.3 mm below the
interaural line. The neurotoxin 5,7-dihydroxytryptamine
hydrobromide (5,7-DHT; Sigma-Aldrich, Poole, UK) was
injected into the median and dorsal raphe nuclei of the rats
in the lesioned group; the control group received sham
injections into the same areas. The dose of 5,7-DHT
injected into the dorsal and median raphe nuclei was 4 μg
base dissolved in 1 μl vehicle (0.9%, w/v sodium chloride
solution with 0.1% ascorbic acid) in each case. The
injection rate was 0.1 μl per 15 s, and the cannula was
left in position for a further 3 min after the completion of
the injection in each site.
Apparatus
The rats were trained in operant conditioning chambers
(Campden Instruments Limited, Sileby, UK) of internal
dimensions 20 cm×23 cm×22.5 cm. One wall of the
chamber contained a recess into which a motor-operated
dipper could deliver 50 μl of a liquid reinforcer. Apertures
were situated 5 cm above and 2.5 cm on either side of the
recess; a motor-driven retractable lever could be inserted into
the chamber through each aperture. Each lever could be
depressed by a force of approximately 0.2 N. The chamber
was enclosed in a sound-attenuating chest; masking noise
was provided by a rotary fan. Twelve chambers were used,
and each rat was always tested in the same chamber. An
Acorn microcomputer, programmed in Arachnid BASIC
(CeNeS Ltd, Cambridge, UK), located in an adjoining room,
controlled the schedules and recorded the behavioral data.
Behavioral training
Two weeks after surgery, the food deprivation regimen was
introduced and the rats were gradually reduced to 80% of
their free-feeding body weights. They were then trained to
press the levers and were exposed to a discrete-trials
continuous reinforcement schedule, in which the two levers
were presented in random sequence, for three sessions.
Thereafter, the rats underwent 50 min training sessions
under the free-operant psychophysical procedure, 7 days a
week, at the same time each day during the light phase of
the daily cycle (between 0700 and 1400 h). The reinforcer,
a 0.6-M solution of sucrose in distilled water, was prepared
daily before each session.
The free-operant psychophysical procedure was identical
to that used by Chiang et al. (1998, 2000a, b). Each session
consisted of fifty 50-s trials, successive trials being
separated by 10-s intertrial intervals. In 40 of the 50 trials,
reinforcement was provided on a constant-probability
variable-interval 30-s schedule (Catania and Reynolds
1968). The levers were inserted into the chamber at the
start of each trial and were withdrawn during the intertrial
interval. During the first 25 s of the trial, reinforcers were
delivered only for responses on lever A, whereas during the
last 25 s, reinforcers were delivered only for responses on
lever B. The positions of lever A and lever B (left versus
right) were counterbalanced across subjects. Four of the 50
trials in each session were probe trials, in which no
reinforcers were delivered. The remaining six trials were
forced-choice trials, in which only one lever was present in
the chamber (lever A three trials; lever B three trials). The
probe and forced-choice trials were interspersed randomly
among the standard trials, with the constraint that at least
one standard trial occurred between successive probe or
forced-choice trials. In the standard and probe trials,
switching between the two levers was restricted to one
switch per trial: in each trial, the first response on lever B
triggered the withdrawal of lever A until the start of the
next trial (Chiang et al. 1998).
Drug treatment
The drug treatment regimen started after >90 sessions of
preliminary training under the free-operant psychophysical
procedure. Injections of drugs were given on Tuesdays and
Fridays and injections of vehicle-alone on Mondays and
Thursdays; no injections were given on Wednesdays,
Saturdays, or Sundays. In order to accrue a sufficient
number of probe trials to obtain reliable estimates of the
timing indices for individual rats, each active treatment was
administered on five occasions, in a pseudorandom se-
quence. Subcutaneous (s.c.) injections were given using a
26-gauge needle at a volume of 1.0 ml kg
−1; intraperitoneal
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volume of 2.5 ml kg
−1.
(−)-Quinpirole hydrochloride 0.08 mg kg
−1, d-amphet-
amine sulfate 0.4 mg kg
−1, and 6-chloro-2,3,4,5-tetrahydro-
1-phenyl-1H-3-benzazepine HBr (SKF-81297) 0.8 mg kg
−1
were dissolved in 0.9% NaCl solution. Quinpirole and d-
amphetamine were injected i.p. and SKF-81297 s.c. All
injections were given 15 min before the start of the
experimental session.
The doses of the drugs were selected on the basis of
previous studies which had shown that these doses
produced approximately equivalent effects on the timing
performance of rats trained under the free-operant psycho-
physical procedure (see “Discussion” for references).
Quinpirole and SKF-81297 were obtained from Tocris
Cookson (Avonmouth, UK); d-amphetamine was obtained
from Sigma (Poole, UK).
Biochemical assays
At the end of the experiment, the rats were killed, their
brains removed, and the following areas were dissected out
on ice: parietal cortex, hippocampus, amygdala, nucleus
accumbens, and hypothalamus. The concentrations of 5-
HT, 5-hydroxyindoleacetic acid (5-HIAA), noradrenaline,
and dopamine in each region were measured by high-
performance liquid chromatography combined with elec-
trochemical detection. The method was as described by
Wogar et al. (1992), with the exception that the mobile
phase for the indoleamine assay was 0.1 M sodium citrate
buffered to pH 2.45 containing 75% (w/v) acetonitrile and
1 mM octanesulfonic acid (ion pair agent); N-w-methyl-5-
hydroxytryptamine was used as the internal standard in the
indoleamine assay. The five brain regions included areas
principally innervated by the median raphe nucleus (hip-
pocampus), the dorsal raphe nucleus (nucleus accumbens),
and by both nuclei (amygdala and neocortex; Imai et al.
1986).
Data analysis
Only the data collected from the probe trials were used in
the analysis. The effects of the three drugs were analyzed
separately. For each drug, comparisons were made between
the data collected in the drug treatment sessions and the
data collected in the immediately preceding sessions in
which the vehicle alone was administered.
Relative response rate Each 50-s trial was divided into 5-s
time-bins. The mean response rate on each lever in
successive time-bins was calculated for each rat under each
treatment condition. The data were analyzed by three-factor
analyses of variance (group [sham lesion, 5,7-DHT lesion] ×
treatment [drug, vehicle] × time-bin) with repeated measures
on the second and third factors.
Psychometric functions A two-parameter logistic function
was fitted to the relative response rate data: %B ¼ 100= 1þ ð
½t=T50 
eÞ,w h e r et is time from trial onset, T50 (the
indifference point) is a parameter expressing the time
at which %B=50%, and ɛ is the slope of the function (Al-
Zahrani et al. 1996; ɛ has a negative value in the case of
ascending functions). The curve-fitting procedure yields
estimates of the values of T50 and ɛ, from which the Weber
fraction was determined as follows. The limen was defined
as half the difference between T75 and T25 (T75 and T25 are
the values of t corresponding to %B=75% and %B=25%),
and the Weber fraction was defined as limen/T50.G o o d n e s s
of fit of the functions was expressed as the index of
determination, p
2. The values of T50, ɛ, and the Weber
fraction derived from the individual subjects were analyzed
using two-factor analyses of variance (group [sham lesion,
5,7-DHT lesion] × treatment [drug, vehicle]) with repeated
measures on the latter factor.
Overall response rate Overall response rate, calculated for
each rat under each treatment condition, was analyzed in
the same way as the parameter values (see above).
A significance criterion of P<0.05 was used in all
analyses.
Results
In both groups, under all treatment conditions, response rate
on lever A declined and response rate on lever B increased as
a function of time from trial onset, and the proportion of
responding allocated to lever B (%B) increased progressively
as a function of time from trial onset. Logistic psychometric
functions provided a good description of the data, the mean
values of p
2 being >0.88 under all treatment conditions in
both groups (Table 1–3).
Quinpirole
The relative response rate (%B) data are shown in Fig. 1.
Quinpirole produced a leftward displacement of the timing
function in both groups. Analysis of variance revealed
significant main effects of treatment [F(1, 22)=12.5,
P<0.01] and time-bin [F(9, 198)=322.2, P<0.001] and a
significant treatment × time-bin interaction [F(9, 198)=5.8,
P<0.001]. There was no significant main effect of group,
nor any significant interaction involving the group factor [all
Fs<1].
The group mean values of the parameters of the
psychometric functions and overall response rate (±SEM)
550 Psychopharmacology (2009) 203:547–559are shown in Table 1 and the effects of quinpirole on each
variable (drug − vehicle differences) in the two groups are
shown in Fig. 2.
Indifference point, T50 Quinpirole reduced T50 in both
groups. There was a significant main effect of treatment
[F(1, 22)=14.8, P<0.001]; there was no significant effect
of group and no significant group × treatment interaction
[Fs<1].
Slope, ɛ Quinpirole increased ɛ in both groups (i.e., ɛ was
less strongly negative under the drug treatment condition
than under the vehicle condition). The main effect of
treatment was significant [F(1, 22)=5.1, P<0.05], but there
was no significant group effect [F<1] and no significant
interaction [F(1, 22)=2.1, NS].
Weber fraction Quinpirole increased the Weber fraction in
both groups. The main effect of treatment was significant
[F(1, 22)=9.4, P<0.01], but there was no significant group
effect and no significant interaction [Fs<1].
Overall response rate Quinpirole reduced overall response
rate in both groups. The effect of treatment was significant
[F(1, 22)=38.9, P<0.001], but there was no significant
group effect and no significant interaction [Fs<1].
d-Amphetamine
The relative response rate (%B) data are shown in Fig. 3. d-
Amphetamine produced a leftward displacement on the
timing function in the sham-lesioned group, but not in the
5,7-DHT-lesioned groups. Analysis of variance revealed
significant main effects of treatment [F(1, 22)=4.9, P<
0.05] and time-bin [F(9, 198)=278.1, P<0.001] and a
significant treatment × time-bin interaction [F(9, 198)=7.2,
P<0.001]. There was no significant main effect of group,
Table 1 Effect of quinpirole on quantitative timing parameters and overall response rate (mean ± SEM)
Parameter Sham lesion 5,7-DHT lesion
Vehicle Quinpirole Vehicle Quinpirole
Indifference point, T50 (s) 14.7±1.8 9.6±1.0* 14.5±1.5 10.7±0.8*
Slope, ɛ −4.3±0.4 −3.9±0.9* −5.2±0.6 −3.1±0.3*
Weber fraction 0.31±0.05 0.40±0.05* 0.25±0.03 0.40±0.04*
p
2 0.97±0.02 0.98±0.01 0.98±0.01 0.98±0.01
Overall response rate (responses min
−1) 47.0±7.8 29.2±4.2* 48.0±5.4 31.1±3.0*
*P<0.05, significant difference from vehicle-alone condition
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Fig. 1 Effects of quinpirole 0.08 mg kg
−1 on performance in the free-
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552 Psychopharmacology (2009) 203:547–559but the group × treatment interaction was significant [F(1, 22]=
5.3, P<0.05]. The group × time-bin [F(9, 198)=1.6, NS] and
the three-way interaction [F<1] were not statistically
significant.
The group mean values of the parameters of the
psychometric functions and overall response rate (±SEM)
are shown in Table 2 and the effects of d-amphetamine on
each variable (drug – vehicle differences) in the two groups
are shown in Fig. 4.
Indifference point, T50 d-Amphetamine reduced T50 in the
sham-lesioned group; this effect was considerably attenuated
in the 5,7-DHT-lesioned group. This was reflected in the
analysis of variance, which showed a significant main effect
of treatment [F(1, 22)=11.8, P<0.01] and a significant
group × treatment interaction [F(1, 22)=4.8, P<0.05]. The
main effect of group was not significant [F<1].
Slope, ɛ d-Amphetamine did not significantly alter the
value of ɛ. There was no significant main effect of
treatment [F(1, 22)=3.7, NS] or group [F<1], and no
significant interaction [F<1].
Weber fraction d-Amphetamine did not significantly alter
the Weber fraction. There was no significant main effect of
treatment [F(1, 22)=4.0, NS] or group [F<1], and no
significant interaction [F<1].
Overall response rate d-Amphetamine reduced overall
response rate in both groups. The effect of treatment
was significant [F(1, 22)=38.0, P<0.001], but there was
no significant group effect and no significant interaction
[Fs<1].
SKF-81297
The relative response rate (%B) data are shown in Fig. 5.
SKF-81297 produced a leftward displacement on the timing
function in both groups. Analysis of variance revealed
significant main effects of treatment [F(1, 22)=20.0, P<
0.001] and time-bin [F(9, 198)=307.7, P<0.001] and a
significant treatment × time-bin interaction [F(9, 198)=
11.4, P<0.001]. There was no significant main effect of
group, nor any significant interaction involving the group
factor [all Fs<1].
The group mean values of the parameters of the
psychometric functions and overall response rate (±SEM)
are shown in Table 3 and the effects of SKF-81297 on each
variable (drug − vehicle differences) in the two groups are
shown in Fig. 6.
Indifference point, T50 SKF-81297 reduced T50 in both
groups. There was a significant main effect of treatment [F(1,
22)=21.6, P<0.001]; there was no significant effect of group
and no significant group × treatment interaction [Fs<1].
Slope, ɛ SKF-81297 increased ɛ in both groups. The main
effect of treatment was significant [F(1, 22)=10.4, P<0.01],
but there was no significant group effect and no significant
interaction [Fs<1].
Weber fraction SKF-81297 increased the Weber fraction in
both groups. The main effect of treatment was significant
[F(1, 22)=14.4, P<0.01], but there was no significant
group effect and no significant interaction [Fs<1].
Overall response rate SKF-81297 reduced overall response
rate in both groups. The effect of treatment was significant
[F(1, 22)=64.4, P<0.001], but there was no significant
group effect and no significant interaction [Fs<1].
Biochemical data
Table 4 shows the concentrations of 5-HT and 5-HIAA,
noradrenaline, and dopamine in the brain areas of the rats
belonging to the two groups. The levels of 5-HT and 5-
Table 2 Effect of d-amphetamine on quantitative timing parameters and overall response rate (mean ± SEM)
Parameter Sham lesion 5,7-DHT lesion
Vehicle d-Amphetamine Vehicle d-Amphetamine
Indifference point, T50 (s) 15.9±1.9 11.4±1.3* 14.8±1.2 13.8±1.5
Slope, ɛ −5.0±0.6 −4.0±0.4 −4.7±0.6 −3.6±0.7
Weber fraction 0.28±0.05 0.34±0.06 0.28±0.04 0.46±0.09
p
2 0.97±0.01 0.94±0.04 0.98±0.01 0.94±0.02
Overall response rate (responses min
−1) 47.3±6.8 32.5±7.3* 47.0±5.5 27.8±4.7*
*P<0.05, significant difference from vehicle-alone condition
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(conventions as in Fig. 2). d-
Amphetamine reduced T50 in the
sham-lesioned group; this effect
was significantly attenuated in
the 5,7-DHT-lesioned group
(significance of between group
difference, *P<0.05). Response
rate was reduced in both groups
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554 Psychopharmacology (2009) 203:547–559HIAA in the lesioned group reduced by >80% compared to
the sham-lesioned group in all areas assayed [t test:
P<0.001 in each case]. There was no significant effect of
the lesion on the levels of the catecholamines in any brain
region examined.
Discussion
In agreement with previous findings with Stubbs’ free-
operant psychophysical procedure (Stubbs 1976; Bizo and
White 1994a, b; Chiang et al. 2000a, b; Machado and
Table 3 Effect of SKF-81297 on quantitative timing parameters and overall response rate (mean ± SEM)
Parameter Sham lesion 5,7-DHT lesion
Vehicle SKF-81297 Vehicle SKF-81297
Indifference point, T50 (s) 14.8±2.0 7.8±1.2* 14.1±1.1 9.0±1.4*
Slope, ɛ −4.3±0.5 −3.1±0.5* −4.6±0.5 −2.6±0.4*
Weber fraction 0.33±0.06 0.51±0.09* 0.28±0.04 0.56±0.07*
p
2 0.98±0.06 0.88±0.03 0.98±0.01 0.89±0.03
Overall response rate (responses min
−1) 49.3±7.3 15.3±1.9* 47.2±5.6 15.8±1.8*
*P<0.05, significant difference from vehicle-alone condition
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Fig. 6 Effects of SKF-81297
0.8 mg kg
−1 on the indifference
time (T50), the slope of the
psychometric function (ɛ), and
the Weber fraction derived from
the psychometric functions
and overall response rate
(conventions as in Fig. 2). SKF-
81297 reduced T50, increased ɛ
and the Weber fraction, and
reduced overall response rate in
both groups. There were no
significant differences between
the two groups
Psychopharmacology (2009) 203:547–559 555Guilhardi 2000; Body et al. 2003, 2004, 2006a, b; Cheung
et al. 2006, 2007a, b, c), response rate on lever A declined,
while response rate on lever B increased, as a function of
time from trial onset, this being reflected in an increasing
percentage of total responding being devoted to lever B (%
B) as the trial progressed. The schedule employed in these
experiments was the ‘constrained-switching’ version of the
free-operant psychophysical procedure, in which the first
response on lever B in each trial results in removal of lever
A from the operant chamber; this has the advantage of
precluding repetitive switching between the levers (Chiang
et al. 1998). This version of the schedule results in more
precise temporal differentiation (steeper psychometric
functions and lower Weber fractions) than the conventional
(‘unconstrained switching’) version, in which the subject is
able to freely switch back and forth between the two levers
throughout the trial (Chiang et al. 1998, 1999, 2000a, b). It
is noteworthy that in these experiments the values of T50 are
considerably shorter than the ‘transition point’ (the point at
which reinforcer allocation was changed from lever A to
lever B) of 25 s from trial onset. This appears to be a
feature of the constrained switching version of this task as
other experiments using this schedule consistently report
values of T50 that are shorter than the ‘transition point’
(Chiang et al. 1998, 1999, 2000a, b; Body et al. 2004,
2006a, b; Cheung et al. 2006, 2007a, b, c). The reason for
this discrepancy between the value of T50 and the
‘transition point’ in the constrained switching version of
the free-operant psychophysical procedure remains unclear.
One possible explanation (Ho et al. 1998) is that the first
reinforcer delivered for responding on lever B strengthens
the act of switching from A to B, resulting in a tendency to
switch ‘early’; since switching from B to A is not permitted
by the schedule, early switching is reflected in a shortening
of T50. Although intuitively reasonable, this interpretation
fails to account for the finding of Chiang et al. (1998, 1999)
that the value of T50 was not affected by removal and
reinstatement of the constraint on switching, or for the
finding by Chiang et al. (1999) and others (Al-Zahrani et al.
1996; Al-Ruwaitea et al. 1999; Body et al. 2001) that
central 5-HT depletion markedly facilitates switching on a
number of concurrent schedule procedures, including the
free-operant psychophysical procedure, without significantly
altering the steady-state value of T50.
In both groups, quinpirole and SKF-81297 reduced the
value of T50; this is consistent with previous findings with
these drugs (Cheung et al. 2007a, b). Quinpirole is a D2-
like dopamine receptor agonist with high affinity for D2,
D3,a n dD 4 receptors and very little affinity for D1
dopamine receptors or 5-HT receptors (Sokoloff et al.
1990; Van Tol et al. 1991; Levant et al. 1992; Seeman and
Van Tol 1994; Tang et al. 1994; Millan et al. 2002;
Moreland et al. 2004). Quinpirole’s effect on temporal
differentiation performance in the free-operant psychophys-
ical procedure has previously been shown to be attenuated
by the “D2 receptor-preferring” antagonists haloperidol,
eticlopride, and sulpiride, but not by the selective D3
receptor antagonist nafadotride, the selective D4 receptor
antagonist L-745870, or the selective D1 receptor antagonist
SKF-83566 (Cheung et al. 2007a). SKF-81297 has also
been previously shown to decrease the value of T50 in this
schedule, an effect which is antagonized by the D1 receptor
antagonist SKF-83566, but not by haloperidol (Cheung et
al. 2007b). The inability of 5-HT depletion to modify the
effects of quinpirole and SKF-81297 suggests that the effect
of direct stimulation of D1 and D2 dopamine receptors by
agonists selective for these receptor subtypes is not
dependent on an intact 5-HTergic system.
In the sham-lesioned group, d-amphetamine produced a
leftward displacement of the psychometric function and a
corresponding decrease in T50, consistent with previous
findings (Chiang et al. 2000a;C h e u n ge ta l .2006;B o d ye t
al. 2006b). This effect of d-amphetamine was attenuated by
depletion of forebrain 5-HT in the 5,7-dihydroxytryptamine-
lesioned group, indicating that an intact 5-HTergic system is
Table 4 Concentrations of monoamines in the brains of the 5,7-DHT-
lesioned and sham-lesioned groups
Region Concentration (ng g
−1, wet weight) ±SEM
Sham
lesion
5,7-DHT
lesion
Percent
sham
5-HT
Parietal cortex 235±15 43±10 18.2*
Hippocampus 315±19 43±9 13.7*
Amygdala 635±30 62±10 9.7*
Nucleus accumbens 769±56 63±16 8.2*
Hypothalamus 805±36 105±22 13.1*
Noradrenaline
Parietal cortex 235±7 214±9 91.3
Hippocampus 331±9 310±9 93.6
Amygdala 435±9 425±11 97.6
Nucleus accumbens 197±19 186±15 94.7
Hypothalamus 1093±88 1149±70 105.1
5-HIAA
Parietal cortex 190±9 17±5 9.1*
Hippocampus 327±17 27±5 8.1*
Amygdala 503±22 47±11 9.3*
Nucleus accumbens 635±30 48±13 7.5*
Hypothalamus 710±81 100±18 14.1*
Dopamine
Parietal cortex 193±26 184±23 95.7
Hippocampus 35±4 32±4 89.7
Amygdala 553±36 546±31 98.7
Nucleus accumbens 5072±319 4936±296 97.3
Hypothalamus 367±19 393±16 107.1
*P<0.001, significant difference between groups
556 Psychopharmacology (2009) 203:547–559required for d-amphetamine to exert its effects on temporal
differentiation (see below).
The doses of the three agonists used in this experiment
were selected on the basis of previous experiments with d-
amphetamine (Chiang et al. 2000a; Cheung et al. 2006;
Body et al. 2006b), quinpirole (Cheung et al. 2007a,c), and
SKF-81297 (Cheung et al. 2007b), which indicated that
these doses produced approximately equivalent effects on
T50 in the free-operant psychophysical procedure. Visual
inspection of the present data suggests that d-amphetamine
had a somewhat smaller effect than the other two agonists
(see Figs. 1, 3, and 5). It should be noted that only a single
dose of each agonist was employed in this experiment, and
therefore it is not possible to state whether the diminished
ability of d-amphetamine to reduce T50 following 5-HT
depletion would have been surmountable with higher doses.
The mechanisms underlying d-amphetamine’s effect on
temporal differentiation performance in the free-operant
psychophysical procedure remain unclear at this time. The
present results, together with the evidence reviewed above,
indicate that both dopaminergic and 5-HTergic mechanisms
are likely to be involved. It is well established that d-
amphetamine promotes the release not only of dopamine
but also of 5-HT and noradrenaline (Fuxe and Ungerstedt
1970; Kucenski and Segal 1989; Seiden and Sabol 1993;
Rothman et al. 2001), raising the possibility that d-
amphetamine’s effect on T50 is brought about by the
simultaneous release of dopamine and 5-HT. However, if
that were the case, it might be expected that blockade of
both D1 dopamine receptors and 5-HT2A receptors would
be needed in order to produce a complete antagonism of d-
amphetamine’s effect on T50. The fact that d-amphetamine’s
effect on timing performance could be completely abol-
i s h e db yb l o c k a d eo fe i t h e rD 1 receptors or 5-HT2A
receptors (Body et al. 2006b; Cheung et al. 2006, 2007b)
suggests a serial rather than a parallel arrangement of
dopaminergic and 5-HTergic mechanisms. One possibility
is that 5-HTergic mechanisms may play a “permissive” role in
dopamine release. Such a mechanism could account for the
lossofd-amphetamine’s effect and the survival of quinpirole’s
and SKF-81297’s effects following central 5-HT depletion.
Thus, 5-HT depletion may reduce d-amphetamine’s ability to
release dopamine from presynaptic terminals, whereas it
would not be expected to affect the interaction of directly
acting agonists with postsynaptic D1 and D2 dopamine
receptors. The involvement of such a mechanism in the
regulation of interval timing is speculative. However, there is
evidence that 5-HT2A receptor-mediated facilitation of dopa-
mine release occurs in the striatum and medial prefrontal
cortex (Sershen et al. 2000; Pehek et al. 2001;A l e xa n d
Pehek 2007).
The lesion employed in the present experiment entailed
“global” depletion of 5-HT from the forebrain, and
therefore does not provide information about the anatomical
location of the 5-HT-dopamine interaction underlying d-
amphetamine’s effects on interval timing. Further work
using local destruction of 5-HTergic terminals in different
regions will be needed to address this question. Subregions
of the corpus striatum and prefrontal cortex may be suitable
initial targets for this endeavor, as these regions have been
implicated in the control of interval timing (Gibbon et al.
1997; Meck and Benson 2002; Matell and Meck 2004;
Meck 2006).
The present experiment did not seek to identify the
species of 5-HT receptor that may be involved in d-
amphetamine’s effects on timing performance. Previous
experiments have shown that 5-HT2A receptor stimulation
can displace the psychometric timing function to the left in
the free-operant psychophysical procedure and other imme-
diate timing schedules (e.g., Body et al. 2004;A s g a r ie ta l .
2006). Our recent finding that d-amphetamine’se f f e c to n
temporal differentiation could be antagonized by the
selective 5-HT2A receptor antagonist MDL-100907 (Body
et al. 2006b) is consistent with the notion that 5-HT2A
receptor stimulation is an important component of 5-HT–
dopamine interactions that may be involved in regulating
interval timing behavior. The location of these 5-HT2A
receptors is uncertain and requires further investigation. The
dorsal striatum is an unlikely candidate, despite its putative
key role in interval timing (Gibbon et al. 1997;M e c ka n d
Benson 2002; Matell and Meck 2004;M e c k2006), since
direct injection of the 5-HT2A/2C receptor agonist DOI into
this region was found not to affect timing performance
(Body et al. 2006a).
5-HT2A receptors are not the only type of 5-HT receptor
that mediate effects on timing performance; 5-HT1A
receptor stimulation has been shown to exert a qualitatively
similar effect to 5-HT2A receptor stimulation on temporal
differentiation in the free-operant psychophysical procedure
(Body et al. 2002, 2004) and the fixed-interval peak
procedure (Asgari et al. 2006). Interestingly, it has been
proposed that 5-HT1A receptors may regulate dopamine
release in the prefrontal cortex, and that this may constitute
a final common pathway of the action of atypical
antipsychotics (Bantick et al. 2001; Ichikawa et al. 2001).
The possible involvement of 5-HT1A receptors in d-
amphetamine’s effect on timing behavior has yet to be
investigated.
Both quinpirole and SKF-812997 increased the Weber
fraction, indicating a reduction of the precision of temporal
differentiation. In neither case was there a differential effect
in the two groups. d-Amphetamine appeared to have a
qualitatively similar effect, although the change in the
Weber fraction was not statistically significant in this case.
It is doubtful whether this reflects a true difference between
the effects of d-amphetamine and the direct receptor
Psychopharmacology (2009) 203:547–559 557agonists, as several previous studies have found a statisti-
cally significant effect of d-amphetamine on the Weber
fraction (Chiang et al. 2000a; Cheung et al. 2006, 2007c).
In agreement with previous findings (Body et al. 2006b;
Cheung et al. 2006, 2007a, b), d-amphetamine, quinpirole,
and SKF-81297 all produced significant reductions of
overall response rate. Interestingly, d-amphetamine’s effect
on response rate was not affected by 5-HT depletion. This
suggests that while d-amphetamine’s effect on temporal
differentiation requires an intact 5-HTergic system, its
effect on overall response rate does not. This finding also
provides additional support for the claim that different
mechanisms are involved in the effects of psychostimulants
ontimingperformanceandoverallresponserate(Chiangetal.
2000a;O d u me ta l .2002;B o d ye ta l .2004;C h e u n ge ta l .
2007a, b).
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